ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Ultra納斯達克生物科
108.43
-3.3047
-2.96%
盤後:
108.43
0.0000
0.00%
19:30 EDT
成交量:
6,749
成交額:
73.10萬
市值:
9,108.12萬
市盈率:
- -
高:
110.00
開:
110.00
低:
107.04
收:
111.73
52周最高:
126.40
52周最低:
55.34
股本:
84.00萬
流通股本:
84.00萬
量比:
0.46
換手率:
0.80%
股息:
0.33
股息率:
0.30%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
百時美施貴寶就安進擬推出的Opdivo生物類似藥提起訴訟
格隆汇
·
5小時前
百時美施貴寶就奧普迪沃擬推出的生物類似藥起訴安進
路透中文
·
14小時前
吉利德科學攜手巴西衞生部,共促Lenacapavir本地化生產新篇章
美股速递
·
昨天
吉利德科學:持續探索與泛美衞生組織合作,助力各國準備好並擴大長效艾滋病預防措施的普及
美股速递
·
昨天
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/BIB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"Ultra納斯達克生物科","latestPrice":108.43,"timestamp":1789502400000,"preClose":111.7347,"halted":0,"volume":6749,"hourTrading":{"tag":"盘后","latestPrice":108.43,"preClose":108.43,"latestTime":"19:30 EDT","volume":12,"amount":1301.16,"timestamp":1789515007137,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02957630888166341,"floatShares":840000,"shares":840000,"eps":0,"marketStatus":"未開盤","change":-3.3047,"latestTime":"09-15 16:00:00 EDT","open":110,"high":110,"low":107.035,"amount":731000.293114,"amplitude":0.026536,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":111.7347,"sharesOutstanding":1040000,"nav":111.7314,"aum":93854376,"dividendRate":0.003,"bidAskSpread":0.002339,"postHourTrading":{"tag":"盘后","latestPrice":108.43,"preClose":108.43,"latestTime":"19:30 EDT","volume":12,"amount":1301.16,"timestamp":1789515007137,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.460356,"impliedVol":0.491,"impliedVolPercentile":0.784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.460356,"shares":840000,"dividePrice":0.3253,"high":110,"amplitude":0.026536,"preClose":111.7347,"low":107.035,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":108.43,"eps":0,"divideRate":0.003,"volume":6749,"delay":0,"ttmEps":0,"open":110,"prevYearClose":79.7794,"prevWeekClose":109.7741,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":115.08,"twentyDayClose":109.8842,"sixtyDayClose":85.0227},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667267605","title":"百時美施貴寶就安進擬推出的Opdivo生物類似藥提起訴訟","url":"https://stock-news.laohu8.com/highlight/detail?id=2667267605","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667267605?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:15","pubTimestamp":1789524901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1868836757.USD","LU1992135399.USD","PJP","LU0114720955.EUR","LU2125154778.USD","BIB","AMGN","LU0289739699.SGD","BK4566","LU2473716301.USD","XPH","IBBQ","LU1236620834.HKD","LU2272731600.USD","LU2468319806.SGD","BK4139","LU1023059063.AUD","LU0320765992.SGD","PBE","IE00BSNM7G36.USD","LU1989771016.USD","FTXH","LU1236620750.USD","LU1670711123.USD","LU0058720904.USD","PPH","LU0868494617.USD","TBXU","LU1868836591.USD","BBH","LU0225284248.USD","IE00B4R5TH58.HKD","IHE","IE0009355771.USD","BK4585","LU2272731865.HKD","LU1868837300.USD","LU0109394709.USD","LU0061475181.USD","LU1983299246.USD","BK4588","LU1883839398.USD","LU2322448957.HKD","LU1261432733.SGD","BK4559","BK4533","IBB","BK4534","BMY","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629132","title":"百時美施貴寶就奧普迪沃擬推出的生物類似藥起訴安進","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629132","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629132?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 01:29","pubTimestamp":1789493363,"startTime":"0","endTime":"0","summary":"百时美施贵宝就奥普迪沃拟推出的生物类似药起诉安进Blake Brittain路透9月15日-百时美施贵宝公司和小野制药公司已在特拉华州联邦法院起诉安进公司,试图阻止安进公司在美国推出其畅销癌症免疫疗法药物“欧迪沃”的生物类似药。百时美施贵宝和小野制药的发言人尚未立即回应置评请求。共同开发“欧狄沃”的百时美施贵宝和小野制药指控,安进的生物类似药将侵犯该药物所涉及的七项美国专利,并请求法院在专利有效期内禁止该生物类似药的销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4T4571DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","PBE","BK4585","AMGN","LU1670711040.USD","LU0432979614.USD","LU0320765992.SGD","IBB","LU1989771016.USD","LU0456855351.SGD","LU0889565916.HKD","LU0225284248.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","PJP","LU1074936037.SGD","LU2468319806.SGD","IE0002141913.USD","BK4139","BK4533","BK4559","LU2242646821.SGD","04332","LU1093756325.SGD","LU1868836757.USD","LU2089984988.USD","BK4534","BK4588","LU1571399168.USD","BMY","LU0289739699.SGD","IE00BFXG1179.USD","IE00BSNM7G36.USD","BK4007","LU2133065610.SGD","LU0306807586.USD","LU0321505868.SGD","LU0096364046.USD","LU0321505439.SGD","LU0109394709.USD","LU1670710661.SGD","BK4532","LU0237698245.USD","LU0114720955.EUR","LU1236620750.USD","LU1585245621.USD","LU0882574055.USD","LU0225771236.USD","LU1291159041.SGD","BK4581","LU1093756168.USD","LU1236620834.HKD","LU0306806265.USD","LU1032466523.USD","LU1868837300.USD","LU0061475181.USD","LU1718418525.SGD","LU0122379950.USD","LU2360032135.SGD","LU1868836591.USD","LU1261432733.SGD","LU2125154935.USD","LU1057294990.SGD","LU0985481810.HKD","BIB","LU0058720904.USD","IE00B2B36J28.USD","IBBQ","LU2596442595.SGD","LU0267386448.USD","LU1023059063.AUD","LU2125154778.USD","LU1670710588.SGD","LU2242652126.USD","LU1061106388.HKD","LU1323610961.USD","IE00BFTCPJ56.SGD","LU1868836914.USD","LU1883839398.USD","IE00BJT1NW94.SGD","LU1868837136.USD","LU1430594728.SGD","LU1670711123.USD","BBH","FTXH","SG9999001440.SGD","IE0009355771.USD","LU2112291526.USD","LU0868494617.USD","BK4566","TBXU","LU1983299246.USD","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120765496","title":"吉利德科學攜手巴西衞生部,共促Lenacapavir本地化生產新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=1120765496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120765496?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485331,"startTime":"0","endTime":"0","summary":"吉利德科学公司近日透露,正积极与巴西卫生部探索合作良机,旨在助力该国实现Lenacapavir药物的本土生产愿景。这一举措,无疑为巴西医药产业自主化进程注入了强劲动力。据悉,双方的洽谈聚焦于如何深化协作,以切实推进巴西卫生部既定的战略目标——即构建并强化Lenacapavir的本地制造能力。Lenacapavir,作为一款备受瞩目的长效抗逆转录病毒药物,其本地化生产若能落地,对巴西乃至更广泛地区的HIV防治工作意义深远。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU0114720955.EUR","IE00BSNM7G36.USD","BK4139","BK4583","LU1023059063.AUD","LU0289739699.SGD","LU0965509283.SGD","LU1066051498.USD","LU1778281490.HKD","LU0859254822.USD","LU1430594728.SGD","MEDI","LU0320765992.SGD","LU0965509101.SGD","LU2357627491.SGD","SG9999015986.USD","IE00B19Z3581.USD","IE00B3T34201.USD","LU2089984988.USD","BBH","LU2468319806.SGD","GILD","BK4568","LU0122379950.USD","SG9999015945.SGD","IE00B19Z3B42.SGD","LU1057294990.SGD","BK4585","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1674673428.USD","LU1934455277.USD","LU1585245621.USD","LU0109394709.USD","BK4550","LU0058720904.USD","LU0882574055.USD","LU1934455863.HKD","TMED","LU1061106388.HKD","LU1934455194.USD","LU0965508806.USD","TBXU","LU1674673691.USD","BK4566","LU1066053197.SGD","LU1037948897.HKD","LU0234570918.USD","LU0965509010.AUD","LU0823416689.USD","LU1037948541.HKD","IBBQ","BIB","LU0889565916.HKD","LU1839511570.USD","SG9999015952.SGD","BK4532","BMED","IE00B7SZLL34.SGD","LU0861579265.USD","SG9999015978.USD","LU2087621335.USD","BK4578","IE0002270589.USD","LU2112291526.USD","LU2324357040.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158863992","title":"吉利德科學:持續探索與泛美衞生組織合作,助力各國準備好並擴大長效艾滋病預防措施的普及","url":"https://stock-news.laohu8.com/highlight/detail?id=1158863992","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158863992?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485330,"startTime":"0","endTime":"0","summary":"吉利德科学(Gilead Sciences)宣布,将继续探索与泛美卫生组织(PAHO)的合作机会,以支持各国做好充分准备,并推动长效艾滋病预防手段的可及性扩展。这一举措旨在强化全球公共卫生应对体系,尤其是针对中低收入国家的需求,通过技术转移、能力建设及供应链优化等途径,加快长效预防方案的落地与规模化应用。双方的合作重点在于应对实施层面的挑战,确保相关资源能够高效、公平地分配至最需要的人群,从而在更大范围内遏制HIV的传播。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","BK4550","LU0823416689.USD","IE00B3T34201.USD","LU1430594728.SGD","SG9999015945.SGD","BBH","BK4139","BK4588","LU0109394709.USD","LU0320765992.SGD","LU1571399168.USD","IBBQ","LU0965509283.SGD","LU1585245621.USD","MEDI","LU2089984988.USD","BK4578","SG9999015986.USD","LU1066051498.USD","LU1839511570.USD","BK4583","LU0122379950.USD","LU2324357040.USD","LU1674673428.USD","SG9999015978.USD","LU0859254822.USD","LU0882574055.USD","LU0965509010.AUD","LU1057294990.SGD","LU1061106388.HKD","LU2468319806.SGD","LU2112291526.USD","BK4532","LU0965509101.SGD","BMED","LU1934455194.USD","LU1037948541.HKD","LU2357627491.SGD","IBB","LU1674673691.USD","BK4585","TBXU","LU0861579265.USD","LU0234570918.USD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU1037948897.HKD","LU1934455277.USD","BK4568","LU0889565916.HKD","IE00BKVL7J92.USD","LU1066053197.SGD","LU2087621335.USD","LU1934455863.HKD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","BIB","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","TMED","LU0058720904.USD","IE00BSNM7G36.USD","GILD","BK4566","LU0965508806.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":38,"pageCount":1,"totalSize":151,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BIB\",params:#limit:6,delay:false,,,undefined,":[]}}